HBIO
Income statement / Annual
Last year (2023), Harvard Bioscience, Inc.'s total revenue was $112.25 M,
a decrease of 0.96% from the previous year.
In 2023, Harvard Bioscience, Inc.'s net income was -$3.42 M.
See Harvard Bioscience, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$112.25 M
|
$113.34 M
|
$118.90 M
|
$102.10 M
|
$116.18 M
|
$120.77 M
|
$101.88 M
|
$104.52 M
|
$108.66 M
|
$108.66 M
|
| Cost of Revenue |
$46.18 M |
$52.52 M |
$51.25 M |
$44.06 M |
$51.85 M |
$57.59 M |
$54.29 M |
$56.11 M |
$59.94 M |
$59.32 M |
| Gross Profit |
$66.07 M |
$60.82 M |
$67.65 M |
$58.04 M |
$64.32 M |
$63.18 M |
$47.60 M |
$48.42 M |
$48.72 M |
$49.34 M |
| Gross Profit Ratio |
0.59 |
0.54 |
0.57 |
0.57 |
0.55 |
0.52 |
0.47 |
0.46 |
0.45 |
0.45 |
| Research and Development
Expenses |
$11.76 M
|
$12.33 M
|
$10.80 M
|
$8.69 M
|
$10.72 M
|
$10.99 M
|
$5.65 M
|
$5.39 M
|
$6.42 M
|
$4.88 M
|
| General & Administrative
Expenses |
$22.78 M
|
$24.49 M
|
$24.31 M
|
$23.51 M
|
$22.76 M
|
$21.38 M
|
$18.58 M
|
$20.95 M
|
$19.83 M
|
$16.83 M
|
| Selling & Marketing
Expenses |
$24.11 M
|
$25.04 M
|
$24.64 M
|
$19.92 M
|
$23.26 M
|
$24.44 M
|
$21.04 M
|
$20.49 M
|
$20.58 M
|
$18.23 M
|
| Selling, General &
Administrative Expenses |
$46.89 M
|
$49.53 M
|
$48.95 M
|
$43.43 M
|
$46.02 M
|
$45.83 M
|
$39.61 M
|
$41.44 M
|
$40.41 M
|
$35.05 M
|
| Other Expenses |
$5.60 M |
$6.12 M |
$5.84 M |
$5.71 M |
$5.75 M |
-$4.28 M |
-$740,000.00 |
-$179,000.00 |
-$1.26 M |
-$1.14 M |
| Operating Expenses |
$64.50 M |
$67.99 M |
$65.59 M |
$57.82 M |
$62.49 M |
$62.20 M |
$47.70 M |
$49.55 M |
$49.65 M |
$42.51 M |
| Cost And Expenses |
$110.36 M |
$120.50 M |
$116.84 M |
$101.88 M |
$114.34 M |
$119.79 M |
$101.98 M |
$105.66 M |
$109.59 M |
$101.83 M |
| Interest Income |
$0.00 |
$2.55 M |
$1.54 M |
$4.83 M |
$5.41 M |
$0.00 |
$0.00 |
$3,000.00 |
$8,000.00 |
$74,000.00 |
| Interest Expense |
$3.59 M |
$2.25 M |
$1.54 M |
$4.83 M |
$5.41 M |
$5.37 M |
$713,000.00 |
$642,000.00 |
$854,000.00 |
$990,000.00 |
| Depreciation &
Amortization |
$7.00 M
|
$7.58 M
|
$7.62 M
|
$7.63 M
|
$7.73 M
|
$7.84 M
|
$2.91 M
|
$4.27 M
|
$2.82 M
|
$2.58 M
|
| EBITDA |
$8.03 M
|
$944,000.00
|
$11.31 M
|
$5.49 M
|
$7.50 M
|
$5.36 M
|
-$101,000.00
|
$1.80 M
|
$1.73 M
|
$9.29 M
|
| EBITDA Ratio |
0.07 |
-0.01 |
0.06 |
0.05 |
0.06 |
0.02 |
0.02 |
0.01 |
0.01 |
0.08 |
| Operating Income Ratio
|
0.02
|
-0.06
|
0.01
|
-0.01
|
0.01
|
0.01
|
-0
|
-0.03
|
-0.02
|
0.06
|
| Total Other
Income/Expenses Net |
-$4.45 M
|
-$2.25 M
|
-$2.21 M
|
-$7.51 M
|
-$5.88 M
|
-$8.96 M
|
-$1.99 M
|
-$81,000.00
|
-$1.90 M
|
-$2.20 M
|
| Income Before Tax |
-$2.56 M |
-$9.18 M |
-$140,000.00 |
-$7.29 M |
-$5.50 M |
-$8.52 M |
-$2.09 M |
-$3.08 M |
-$3.61 M |
$4.42 M |
| Income Before Tax Ratio
|
-0.02
|
-0.08
|
-0
|
-0.07
|
-0.05
|
-0.07
|
-0.02
|
-0.03
|
-0.03
|
0.04
|
| Income Tax Expense |
$859,000.00 |
$337,000.00 |
$148,000.00 |
$518,000.00 |
-$815,000.00 |
-$3.68 M |
-$1.22 M |
$1.23 M |
$15.43 M |
$2.06 M |
| Net Income |
-$3.42 M |
-$9.52 M |
-$288,000.00 |
-$7.81 M |
-$4.69 M |
-$3.46 M |
-$865,000.00 |
-$4.31 M |
-$19.04 M |
$2.36 M |
| Net Income Ratio |
-0.03 |
-0.08 |
-0 |
-0.08 |
-0.04 |
-0.03 |
-0.01 |
-0.04 |
-0.18 |
0.02 |
| EPS |
-0.0805 |
-0.23 |
-0.0071 |
-0.2 |
-0.12 |
-0.0966 |
-0.0257 |
-0.13 |
-0.57 |
0.07 |
| EPS Diluted |
-0.0805 |
-0.23 |
-0.0071 |
-0.2 |
-0.12 |
-0.095 |
-0.0249 |
-0.13 |
-0.57 |
0.07 |
| Weighted Average Shares
Out |
$42.42 M
|
$41.41 M
|
$40.34 M
|
$38.64 M
|
$37.81 M
|
$35.83 M
|
$33.60 M
|
$34.21 M
|
$33.59 M
|
$32.17 M
|
| Weighted Average Shares
Out Diluted |
$42.42 M
|
$41.41 M
|
$40.34 M
|
$38.64 M
|
$37.81 M
|
$36.45 M
|
$34.75 M
|
$34.21 M
|
$33.59 M
|
$33.24 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
